[en] Emerging infectious animal and zoonotic diseases can inflict significant losses on animal production and public health, and threaten the safety and security of the food system. Threat analysis (forecasting), which monitors the measurable risk indicators of disease emergence, should be in place before the emergence of any threat Animal and public health authorities develop and regularly re-evaluate disease preparedness, response and recovery plans, based on the 'One Health' principle. These plans should include surveillance, biosecurity measures, communication channels and training for personnel. Scenarios for outbreaks of natural emerging infectious disease or bioterrorist events should be prepared and practised. National and international legislation should be regularly updated to provide a robust legal basis to manage outbreaks. Reference laboratories should have reliable and validated diagnostic tools for rapid, high-throughput testing. Strict biosafety, biocontainment and biosecurity control measures must be implemented in laboratories in order to prevent the accidental or malicious release of pathogens. The pharmaceutical industry should be incentivised to develop vaccines and/or antiviral drugs against disease outbreaks. Conventions between public authorities and the pharmaceutical industry should guarantee adequate stockpiling of the pharmaceuticals needed to control large-scale outbreaks. In the early phase of disease emergence (early warning), veterinarians and stakeholders play an important role in early detection at the farm level. Upon notification, veterinary authorities must take rapid response measures to limit disease spread. National and international short-and medium-term strategic research agendas should be developed, based on a comprehensive gap analysis and horizon scan. This planning will help to guide funding agencies and non-governmental organisations in their quest to support relevant research.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Cardoen, S.; Staff Direction for Risk Assessment, Dirct.-General of Control Policy, Federal Agency for the Safety of the Food Chain, Boulevard du Jardin Botanique 55, Brussels, Belgium
De Clercq, K.; Unit of Vesicular and Exotic Diseases, CODA-CERVA, Groeselenberg 99, Brussels, Belgium
Vanholme, L.; Department for Animal Health and Safety of Animal Products, Dirct.-General of Control Policy, Federal Agency for the Safety of the Food Chain, Boulevard du Jardin Botanique 55, Brussels, Belgium
De Winter, P.; Department for Animal Health and Safety of Animal Products, Dirct.-General of Control Policy, Federal Agency for the Safety of the Food Chain, Boulevard du Jardin Botanique 55, Brussels, Belgium
Thiry, Etienne ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Virologie vétérinaire et maladies virales animales
Van Huffei, X.; Staff Direction for Risk Assessment, Dirct.-General of Control Policy, Federal Agency for the Safety of the Food Chain, Boulevard du Jardin Botanique 55, Brussels, Belgium
Language :
English
Title :
Preparedness activities and research needs in addressing emerging infectious animal and zoonotic diseases
Publication date :
2017
Journal title :
Revue Scientifique et Technique. Office International des Epizooties
Pinto VN. (2013).-Bioterrorism: health sector alertness. J. Nat. Sci. Biol. Med., 4 (1), 24-28. doi:10.4103/0976-9668.107256.
Ullibridge S.R, Bell AJ. & Roman R.S. (1999).-Centers for Disease Control and Prevention bioterrorism preparedness and response. Am. J. Inject Control, 27 (6), 463-464. doi:10.1016/S0196-6553(99)70020-9.
Levings R.L (2012).-Emerging and exotic zoonotic disease preparedness and response in the United States-coordination of the animal health component. Zoonoses Public Hlth, 59 (2), 80-94. doi:10.1111/j.l863-2378.2012.01495.x.
Wentholt M, Cardoen S, Imberechts H, Van Huffel X, Ooms B. & Frewer L. (2012).-Defining European preparedness and research needs regarding emerging infectious animal diseases: results from a Delphi expert consultation. Prev. Vet. Med., 103 (2-3), 81-92. doi:10.1016/j. prevetmed.2011.09.02.
DISCONTOOLS (2017).-About DISCONTOOLS. Available at: www.discontools.eu/AboutDiscontools (accessed on 6 August 2017).
Bagni M, Zilli R, Messori S. & Mariano V (2015).-Fore-Med report 2014. Animal health foresight for the Mediterranean. Italian Ministry of Health, Rome. Available at: www.salute.gov.it/imgs/C-17-EventiStampa-260-interviste Relatori-itemInterviste-0-fileAllegatoIntervista.pdf (accessed on 6 August 2017).
Nederlandse Voedsel-en Warenautoriteit (Food and Consumer Product Safety Authority) (NVWA) (2005).-Pan-European identification of emerging risks in the field of food production (PERIAPT). Final report. NVWA, Utrecht, the Netherlands. Available at: www.elika.net/datos/redes-europeas-docs/Documentol/l.Informe%20final %20Emerging%20Risks%20Identification%20Booklet-Periapt.pdf (accessed on 14 August 2017).
Nederlandse Voedsel-en Warenautoriteit (Food and Consumer Product Safety Authority) (NVWA) (2006).-Forming a global system for identifying food-related emerging risks (EMR1SK). EFSA/SC/Tender/01/2004. Final report. NVWA, Utrecht, the Netherlands. doi:10.2903/j.efsa.2005.224r.
European Food Safety Authority (EFSA) (2014).-Drivers of emerging risks and their interactions in the domain of biological risks to animal, plant and public health: a pilot study. EFSA Support. Public, 11 (4), 44 pp. doi: 10.2903/sp.efsa.2014.EN-588.
Scientific Committee of the Federal Agency for the Safety of the Food Chain (Belgium) (2013).-Advice 06-2013 on risk factors of the (potentially) (re)-emerging infectious animal diseases [in French]. Available at: www.faw-afsca.fgov.be/comitescientifique/avis/2013/-documents/AVLS06-2013-FR-DossierSciCom2006-48.pdf (accessed on 7 August 2017).
Scientific Committee of the Federal Agency for the Safety of the Food Chain (Belgium) (2016).-Advice 10-2016 (and appendix) on prospects for a monitoring of risk indicators (threat analysis) for alert setting of emergence of animal diseases [in French]. Available at: www.faw-afsca.fgov.be/comitescientifique/avis/2016/-documents/AvislO-2016-Monitoringemergence-000.pdf. Appendix available at: www.faw-afsca.fgov.be/comitescientifique/avis/2016/-documents/Avisl0-2016-Monitoringemergence-Appendix.pdf (accessed on 7 August 2017).
Food and Agriculture Organization of the United Nations (FAO), World Organisation for Animal Health (OIE) & World Health Organization (WHO) (2008).-The FAO-OIE-WHO collaboration: sharing responsibilities and coordinating global activities to address health risks at the animal-human-ecosystem interfaces. A tripartite concept note. FAO, Rome; OIE, Paris; WHO, Geneva. Available at: www.who.int/influenza/resources/documents/tripartite-concept-note-hanoi-04201 l-en.pdf (accessed on 7 August 2017).
World Organisation for Animal Health (OIE) (2017).-Terrestrial Animal Health Code. OIE, Paris. Available at: www.oie.int/international-standard-setting/terrestrial-code/access-online/(accessed on 7 August 2017).
World Organisation for Animal Health (OIE) (2017).-Aquatic Animal Health Code. OIE, Paris. Available at: www.oie.int/international-standard-setting/aquatic-code/access-online/(accessed on 7 August 2017).
Welby S., van Schalk G., Veldhuis A., Brouwer-Middelesch H., Peroz C, Santman-Berends I.M., Fourichon C, Wever P. & Van der Stede Y. (2016).-Effectiveness and cost efficiency of different surveillance components for proving freedom and early detection of disease: bluetongue serotype 8 in cattle as case study for Belgium, France and the Netherlands. Transbound. Emerg. Dis. doi:10.1111/tbed.l2564.
World Organisation for Animal Health (OIE) (2017).-Chapter 1.1.6. Principles and methods of validation of diagnostic assays for infectious diseases. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. OIE, Paris. Available at: www.oie.int/international-standard-setting/terrestrial-manual/access-online/(accessed on 30 August 2017).
World Organisation for Animal Health (OIE) (2017).-Manual of Diagnostic Tests for Aquatic Animals. OIE, Paris. Available at: www.oie.int/international-standard-setting/aquatic-manual/access-online/(accessed on 30 August 2017).
Vannier R, Capua I., Le Potier M.F., Mackay D.K.J., Muylkens B., Parida S., Paton D.J. & Thiry E. (2007).-Marker vaccines and the impact of their use on diagnosis and prophylactic measures. In Animal vaccination-Part 2: scientific, economic, regulatory and socio-ethical aspects (P.-R Pastoret, M. Lombard & A.A. Schudel, eds). Rev. Sci. Tech. Off. Int. Epiz., 26 (2), 351-372.
Brocchi E., Bergmann I.E., Dekker A., Paton D.J., Sammin D.J., Greiner M., Grazioli S., De Simone F., Yadin H., Haas B., Bulut N., Malirat V, Neitzert E Goris N Parida S., Sorensen K. & De Clercq K. (2006).-Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine, 24 (47-48), 6966-6979. doi:10.1016/j.vaccine. 2006.04.050.
Hanon J.B., Vandenberge V, Dentelle M., De Leeuw L, De Clercq K., Van Borm S., Koenen E & Van der Stede Y. (2016).-Inter-laboratory evaluation of the performance parameters of a lateral flow test device for the detection of bluetongue-specific antibodies. J. Vtrol. Methods, 228,140-150. doi:10.1016/j.jviromet.2015.12.001.
Zientara S., Sailleau C, Bréard E., Viarouge C, Doceul V & Vitour D. (2015).-Benefits of PCR and decentralization of diagnosis in regional laboratories in the management of bluetongue in France. Vet. Ita., 51 (4), 393-399. doi:10.12834/Vetlt.512.3148.2.
Tuppurainen E. & Oura C. (2014).-Lumpy skin disease: an African cattle disease getting closer to the EU. Vet. Ree, 175 (12), 300-301. doi:10.1136/vr.g5808.
Nash D., Mostashari E, Fine A., Miller J., O'Leary D., Murray K., Huang A., Rosenberg A., Greenberg A., Sherman M., Wong S. & Layton M. (2001).-The outbreak of West Nile virus infection in the New York City area in 1999. N. Eng. J. Med., 344 (24), 1807-1814. doi:10.1056/NEJM200106143442401.
Anderson I. (2002).-Foot and mouth disease 2001: lessons to be learned inquiry report, HC888. Stationery Office, London. Available at: http.7Avebarchive.nationalarchives. gov.uk/20100807034701/http:/archive.cabinetoffice.gov. uk/fmd/fmd-report/report/index.htm (accessed on 30 June 2016).
Toussaint J.-E, Sailleau C, Mast J., Houdart E, Czaplicki G., Demeestere L., VandenBussche E, Van Dessel W, Goris N., Bréard E., Bounaadja L., Thiry E., Zientara S. & De Clercq K. (2007).-Bluetongue in Belgium. Emerg. Inject. Dis., 13 (4), 614-616. doi:10.3201/eidl304.061136.
European Commission for the Control of Foot-and-Mouth Disease (EuFMD) (2013).-Minimum biorisk management standards for laboratories working with foot-and-mouth disease virus. Version GS40/4.2bis, as adopted by the 40th General Session of the EuFMD Commission, 22-24 April 2013, Rome, Italy. EuFMD, Rome. Available at: www.fao. org/fileadmin/user-upload/eufmd/Lab-guidelines/FMD-Minimumstandards-2013-Final-version.pdf (accessed on 1 July 2016).
Saegerman C, Hubaux M, Urbain B, Lengelé L. & Berkvens D. (2007).-Regulatory issues surrounding the temporary authorisation of animal vaccination in emergency situations: the example of bluetongue in Europe. In Animal vaccination-Part 2: scientific, economic, regulatory and socio-ethical aspects (E-R Pastoret, M. Lombard & AA Schudel, eds). Rev. Sci. Tech. Off. Int. Epiz., 26 (2), 395-413. doi:10.20506/rst.26.2.1747.
Lombard M. & Füssel A.E. (2007).-Antigen and vaccine banks: technical requirements and the role of the European antigen bank in emergency foot and mouth disease vaccination. In Animal vaccination-Part 1: development, production and use of vaccines (P.-P. Pastoret, M. Lombard & A.A. Schudel, eds). Rev. Sd. Tech. Off. Int. Epiz., 26 (1), 117-134.
Palache B. & Krause R. (2009).-Progress with human H5N1 vaccines: a perspective from industry. Expert Rev. Vaccines, 8 (4), 391-400. doi:10.1586/erv.09.16.
World Organisation for Animal Health (OIE) (2016).-OIE Expert Surveillance Panel on Equine Influenza Vaccine Composition, OIE Headquarters, 22 March 2017: conclusions and recommendations. OIE, Paris. Available at: www.oie. int/en/our-scientific-expertise/specific-information-and-recommendations/equine-influenza/(accessed on 25 April 2017).
Dal Pozzo F. & Thiry E. (2014).-Antiviral chemotherapy in veterinary medicine: current applications and perspectives. Rev. Sci. Tech. Off. Int. Epiz., 33 (3), 791-801. doi:10.20506/rst.33.3.2318.
Backer JA, Vrancken R, Neyts J. & Goris N. (2013).-The potential of antiviral agents to control classical swine fever: a modelling study. Antiviral Res., 99 (3), 245-250. doi: 10.1016/j. antiviral.2013.06.013.
European Union (EU) (1982).-European Union Council Directive 82/894/EEC of 21 December 1982 on the notification of animal diseases within the Community. Off. J. Eur. Union, L378, of 31/12/1982, 58-62. Available at: http7/data.europa. eu/eli/dir/1982/894/oj (accessed on 7 August 2017).
European Commission (EC) (2012).-2012/737/EU: Commission Implementing Decision of 27 November 2012 amending Annexes I and II to Council Directive 82/894/EEC on the notification of animal diseases within the Community (notified under document C(2012) 8518). Text with EEA relevance. Off. J. Eur. Union, L329, of 29/11/2012, 19-22. Available at: httpy/data.europa.eu/eli/dec-impl/2012/737/oj (accessed on 7 August 2017).
World Health Organization (WHO) (2016).-International Health Regulations (2005): revised edition, 3rd Ed. WHO, Geneva, 84 pp. Available at: www.who.int/ihr/publications/9789241580496/en/(accessed on 7 August 2017).
Christopher M.M. (2015).-A new decade of veterinary research: societal relevance, global collaboration, and translational medicine. Front. Vet. Sci., 2, 1. doi:10.3389/fvets.2015.00001.
